(Q64948618)

1 July 2019

title

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease. (English)

1 reference

1 July 2019

author

Kina Höglund

16

1 reference

1 July 2019

Henrik Zetterberg

14

Henrik Zetterberg

1 reference

1 July 2019

15

Kaj Blennow

1 reference

1 July 2019

4

Erik Portelius

1 reference

1 July 2019

Thomas G Beach

12

Thomas G Beach

1 reference

1 July 2019

2

Gunnar Brinkmalm

1 reference

1 July 2019

Oskar Hansson

7

Oskar Hansson

1 reference

1 July 2019

Tammaryn Lashley

13

Tammaryn Lashley

1 reference

1 July 2019

Lucilla Parnetti

8

Lucilla Parnetti

1 reference

1 July 2019

author name string

Claudia Cicognola

1

1 reference

1 July 2019

Jessica Wahlgren

3

1 reference

1 July 2019

Johan Gobom

5

1 reference

1 July 2019

Nicholas C Cullen

6

1 reference

1 July 2019

Radu Constantinescu

9

1 reference

1 July 2019

Kristin Wildsmith

10

1 reference

1 July 2019

Hsu-Hsin Chen

11

1 reference

1 July 2019

publication date

13 December 2018

1 reference

1 July 2019

published in

Acta Neuropathologica

1 reference

1 July 2019

volume

137

1 reference

1 July 2019

issue

2

1 reference

1 July 2019

page(s)

279-296

1 reference

1 July 2019

https://scigraph.springernature.com/pub.10.1007/s00401-018-1948-2

exact match

0 references

cites work

Neuropathological stageing of Alzheimer-related changes

1 reference

12 December 2020

A new rating scale for Alzheimer's disease.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

12 December 2020

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

12 December 2020

Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy

1 reference

12 December 2020

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

12 December 2020

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

1 reference

12 December 2020

Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons.

1 reference

12 December 2020

Mild cognitive impairment as a diagnostic entity

1 reference

12 December 2020

Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.

1 reference

12 December 2020

Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS.

1 reference

12 December 2020

N-terminal fragments of tau inhibit full-length tau polymerization in vitro

1 reference

12 December 2020

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

1 reference

12 December 2020

A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator.

1 reference

12 December 2020

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

1 reference

12 December 2020

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

12 December 2020

A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.

1 reference

12 December 2020

Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.

1 reference

12 December 2020

CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder

1 reference

12 December 2020

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

12 December 2020

A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies

1 reference

12 December 2020

Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

1 reference

12 December 2020

An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid

1 reference

12 December 2020

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

1 reference

12 December 2020

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

1 reference

12 December 2020

Criteria for the diagnosis of corticobasal degeneration

1 reference

12 December 2020

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

1 reference

12 December 2020

AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons

1 reference

12 December 2020

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

1 reference

12 December 2020

Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias.

1 reference

12 December 2020

Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

1 reference

12 December 2020

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

1 reference

12 December 2020

Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms

1 reference

12 December 2020

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

1 reference

12 December 2020

1 reference

12 December 2020

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

1 reference

12 December 2020

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates

1 reference

12 December 2020

Expanding the cerebrospinal fluid endopeptidome

1 reference

12 December 2020

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.

1 reference

12 December 2020

Tau Kinetics in Neurons and the Human Central Nervous System

1 reference

12 December 2020

10.1007/S00401-018-1948-2

Identifiers

DOI

1 reference

1 July 2019

PMCID

6514201

1 reference

1 July 2019

PubMed ID

30547227

1 reference

1 July 2019